Intelligent Bio Solutions (INBS) Capital Expenditures (2024 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Capital Expenditures of $14385.0 in Q1 2025, up 663.9% quarter-over-quarter from -$2551.0 in Q1 2024, and up 663.9% on a YoY basis from $1883.1 in Q1 2024.
Intelligent Bio Solutions (INBS) Capital Expenditures (2024 - 2025) Analysis & Trends
Intelligent Bio Solutions' Capital Expenditures history runs 2 years deep, the most recent figure standing at $14385.0 for Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 14,385.00 |
| Mar 31, 2025 | 14,385.00 |
| Mar 31, 2024 | -2,551.00 |
| Mar 31, 2024 | -2,551.00 |